Yamamoto, J
Ohnuma, K
Hatano, R
Okamoto, T
Komiya, E
Yamazaki, H
Iwata, S
Dang, N H
Aoe, K
Kishimoto, T
Yamada, T
Morimoto, C
Article History
Received: 20 January 2014
Accepted: 26 February 2014
First Online: 17 April 2014
Competing interests
: CM is an inventor of the humanised CD26 mAb, YS110 (US Patent #7402698). Y’s Therapeutics Co., Ltd owns this patent, and CM and NHD are founding members of this company.